This review provides a comprehensive coverage of the history, biology and chemistry of tetrodotoxin (TTX). It traces the origin of this remarkable molecule all the way back to the ancient Chinese medicine records. The discovery of biological activity, isolation, and a brief overview of structure elucidation are summarized. Next, the biology of TTX is discussed, primarily in the context of its activity in the sodium channels, its anesthetic properties, and its potential use in cancer treatment or drug addiction. Biosynthesis of TTX is covered before the discussion of the total syntheses. All total, formal or partial syntheses are covered but those total syntheses that have been discussed in previous reviews are only briefly summarized. Finally, the synthesis of natural and unnatural derivatives is surveyed, and a conclusion and outlook are provided for this very extensive field of endeavor. To the best of our knowledge the literature coverage is complete up to December 2018.

Chemistry Department and Centre for Biotechnology Brock University 1812 Sir Isaac Brock Way St Catharines Ontario L2S 3A1 Canada

Department of Organic Chemistry Faculty of Science Charles University Hlavova 8 12843 Prague Czech Republic

Zobrazit více v PubMed

Tetraodon is a genus of the pufferfish family Tetraodontidae.

K. C. Wong, L. T. Wu, History of Chinese Medicine, 2nd ed, National Quarantine Service, Shanghai, 1936.

C. Gaillard, Mem. Inst. Francais Arch. Orient. 1923, 51, 97-100.

C. Y. Kao, Pharmacol. Rev. 1966, 18, 997-1049.

E. Kaempfer, The History of Japan (1690-1693), Translation by J. Scheuchzer, MacLehose, Glasgow, 1906, 1.

F. A. Fuhrman, Ann. N. Y. Acad. Sci. 1986, 479, 1-14.

D. Takahashi, Y. Inoko, Arch. Exp. Pathol. Pharmakol. 1890, 26, 401-418.

D. Takahashi, Y. Inoko, Arch. Exp. Pathol. Pharmakol. 1890, 26, 453-458.

Y. Tahara, J. Pharm. Soc. Jpn. 1909, 29, 587-625;

Y. Tahara, Biochem. Z. 1911, 10, 255-275.

E. G. Moczydlowski, Toxicon 2013, 63, 165-183.

A. Yokoo, J. Chem. Soc. Jpn. 1950, 71, 590-592.

K. Tsuda, M. Kawamura, J. Pharm. Soc. Jpn. 1952, 72, 771-773.

A. Yokoo, S. Morosawa, J. Pharm. Soc. Jpn. 1955, 75, 235-236.

For compilation of misassigned stuctures for the period 1990-2004 see: K. C. Nicolaou, S. A. Snyder, Angew. Chem. Int. Ed. 2005, 44, 1012-1044;

Angew. Chem. 2005, 117, 1036-1069.

For the definition of the concepts of consonance and dissonance see the following discussion: T. Hudlicky, J. W. Reed in The Way of Synthesis, Wiley-VCH, Weinheim, 2007, pp. 186-189; See also a note on pp. 199-200 for the history of this concept as proposed by David Evans;

H. N. C. Wong, M. Y. Hon, C. W. Tse, Y. C. Yip, J. Tanko, T. Hudlicky, Chem. Rev. 1989, 89, 165-198 [Section I.5, page 168].

Indeed, these type of structural peculiarites had not been known before, which complicated the structural elucidation of TTX (see discussion in the text and reference [17a]).

R. B. Woodward, Pure Appl. Chem. 1964, 9, 49-74;

R. B. Woodward, J. Z. Gougoutas, J. Am. Chem. Soc. 1964, 86, 5030.

K. Tsuda, Chem. Pharm. Bull. Jpn. 1964, 12, 634-642.

T. Goto, Y. Kishi, S. Takahashi, Y. Hirata, Tetrahedron 1965, 21, 2059-2088.

H. S. Mosher, F. A. Fuhrmann, H. D. Buchwald, H. G. Fischer, Science 1964, 144, 1100-1110.

A. Yokoo, Proc. Jpn. Acad. 1952, 28, 200-202;

H. Kakisawa, Y. Okumura, Y. Hirata, J. Chem. Soc. Jpn. 1959, 80, 1483-1487.

K. Tsuda, S. Ikuma, M. Kawamura, R. Tachikawa, T. Miyadera, Chem. Pharm. Bull. 1962, 10, 868-870.

T. Goto, Y. Kishi, S. Takahashi, Y. Hirata, Tetrahedron Lett. 1963, 4, 2105-2113.

T. Goto, Y. Kishi, S. Takahashi, Y. Hirata, Tetrahedron Lett. 1963, 4, 2101-2104.

K. Tsuda, C. Tamura, R. Tachikawa, K. Sakai, O. Amakasu, M. Kawamura, S. Ikuma, Chem. Pharm. Bull. 1963, 11, 1473-1475.

E. Marban, T. Yamagishi, G. F. Tomaselli, J. Physiol. 1998, 508, 647-657;

W. A. Catterall, J. Physiol. 2012, 590, 2577-2589;

M. de Lera Ruiz, R. L. Kraus, J. Med. Chem. 2015, 58, 7093-7118.

A. L. Hodgkin, A. F. Huxley, J. Physiol. 1952, 117, 500-544.

W. S. Agnew, S. R. Levinson, J. S. Brabson, M. A. Raftery, Proc. Natl. Acad. Sci. USA 1978, 75, 2606-2610.

W. A. Catterall, A. L. Goldin, S. G. Waxman, Pharmacol. Rev. 2005, 57, 397-409.

T. Narahashi, T. Degushi, N. Urakawa, Y. Ohkubo, Am. J. Physiol. 1960, 198, 934-938;

S. Nakijima, S. Iwasaki, K. Obata, J. Gen. Physiol. 1962, 46, 97-115;

C. Y. Kao, F. A. Fuhrman, J. Pharmacol. Exp. Ther. 1963, 140, 31-40;

T. Narahashi, J. W. Moore, W. R. Scott, J. Gen. Physiol. 1964, 47, 965-974.

Few reports in literature describe that TTX can block Ca2+ currents of specific calcium chnnels. However, high doses are required (EC50=55 μm). For the detailed information, see:

B. Hegyi, I. Komáromi, K. Kistamás, K. Váci, B. Horváth, J. Magyar, T. Bányász, P. P. Nánási, N. Szentandrássy, Mar. Drugs 2013, 11, 2140-2153;

B. Hegyi, L. Bárándi, I. Komáromi, F. Papp, B. Horváth, J. Magyar, T. Bányász, Z. Krasznai, N. Szentandrássy, P. P. Nánási, Pflugers Arch. 2012, 464, 167-174;

N. Akaike, K. Takahashi, J. Physiol. 1992, 450, 529-546.

E. E. J. Kasteel, R. H. S. Westerink, Toxicol. Lett. 2017, 270, 12-16.

C. H. Lee, P. C. Ruben, Channels (Austin) 2008, 2, 407-412.

S. L. Geffeney, P. C. Ruben, Mar. Drugs 2006, 4, 143-156.

T. Tsukamoto, Y. Chiba, M. Wakamori, T. Yamada, S. Tsunogae, Y. Cho, R. Sakakibara, T. Imazu, S. Tokoro, Y. Satake, M. Adachi, T. Nishikawa, M. Yotsu-Yamashita, K. Konoki, Br. J. Pharmacol. 2017, 174, 3881-3892.

G. M. Lipkind, H. A. Fozzard, Biophys. J. 1994, 66, 1-13.

M. Stevens, S. Peigneur, J. Tytgat, Front. Pharmacol. 2011, 2, 1-13.

B. S. Zhorov, D. B. Tikhonov, Curr. Top. Membr. 2016, 78, 117-143;

H. A. Fozzard, G. M. Lipkind, Mar. Drugs 2010, 8, 219-234.

C. J. Huang, L. Schild, E. G. Moczydlowski, J. Gen. Physiol. 2012, 140, 435-454;

R. Cervenka, T. Zarrabi, P. Lukacs, H. Todd, Mar. Drugs 2010, 8, 1373-1393.

Y. Ogura, Y. Mori, Eur. J. Pharmacol. 1968, 3, 58-67.

J. F. Butterworth IV, Reg. Anesth. Pain Med. 2010, 35, 167-176;

Recent research suggests some local anesthetics contribution to myocardiotoxicity via interaction with TTX-sensitive channels. However, involvement of these channels is not as significant as the involvement of NaV1.5: C. Stoetzer, T. Doll, T. Stueber, C. Herzog, F. Echtermeyer, F. Gruelich, C. Rudat, A. Kispert, F. Wegner, A. Leffler, Naunyn-Schmiedeberg′s Arch. Pharmacol. 2016, 389, 625-636.

R. F. Padera, J. Y. Tse, E. Bellas, D. S. Kohane, Muscle Nerve 2006, 34, 747-753.

H. J. Adams, M. R. Blair, Jr., B. H. Takman, Anesth. Analg. 1976, 55, 568-573;

D. S. Kohane, J. Yieh, N. T. Lu, R. Langer, G. R. Strichartz, C. B. Berde, Anesthesiology 1998, 89, 119-131;

C. Berde, U. Athiraman, B. Yahalom, D. Zurakowski, G. Corfas, C. Bognet, Mar. Drugs 2011, 9, 2717-2728;

J. B. McAlvin, C. Yhang, J. C. Dohlman, P. E. Kolovou, B. Salvador-Culla, D. S. Kohane, Invest. Ophthalmol. Visual Sci. 2015, 56, 3820-3826.

H. J. F. Adams, B. H. Takman, DE 216305 A 19721012, 1972;

H. J. Adams, B. H. Takman, US 3966934 A 19760629, 1976;

H. J. Adams, B. H. Takman, US 4022899 A 19770510, 1977;

H. J. Adams, B. H. Takman, US 4029793 A 19770614, 1977;

D. M. Schwartz, H. L. Fields, WO 9843619 A2 19981008, 1998;

Y. Liu, W. Yin, US 20020161013 A1 20021031, 2002;

B. Ku, S. Qi, WO 2002022128 A1 20020321, 2002;

H. Epstein-Barash, D. S. Kohane, WO 2010117996 A1 20101014, 2010.

D. S. Kohane, S. E. Smith, D. N. Louis, G. Colombo, P. Ghoroghchian, N. G. M. Hunfeld, C. B. Berde, R. Langer, Pain 2003, 104, 415-421.

C. Zhan, W. Wang, J. B. McAlvin, S. Guo, B. P. Timko, C. Santamaria, D. S. Kohane, Nano Lett. 2016, 16, 177-181;

C. Zhan, W. Wang, C. Santamaria, B. Wang, A. Rwei, B. P. Timko, D. S. Kohane, Nano Lett. 2017, 17, 660-665;

A. Rwei, C. Zhang, K. J. Cullion, D. S. Kohane, WO 2017062875 A1 20170413, 2017.

S. M. A. El-Dayem, F. M. Fouda, E. H. A. Ali, B. A. A. El Motelp, Toxicol. Ind. Health 2013, 29, 404-417.

S. Roger, M. Potier, C. Vandier, P. Besson, J.-Y. Le Guennec, Curr. Pharm. Des. 2006, 12, 3681-3695;

B. Shan, M. Dong, H. Tang, N. Wang, J. Zhang, C. Yan, X. Jiao, H. Zhang, C. Wang, Oncol. Lett. 2014, 8, 345-350;

P. Rhana, R. R. Trivelato, Jr., P. S. L. Beirão, J. S. Cruz, A. L. P. Rodriguez, Braz. J. Med. Biol. Res. 2017, 50, 6011-6021;

C. Stock, A. Schwab, Biochim. Biophys. Acta Biomembr. 2015, 1848, 2638-2646;

F. M. Mohamed, M. A. Khajah, M. Yang, W. J. Brackenbury, Y. A. Luqmani, Int. J. Oncol. 2016, 48, 73-83.

J. A. Black, S. G. Waxman, Neuron 2013, 80, 280-291.

N. A. Hagen, K. M. Fisher, B. Lapointe, P. du Souich, S. Chary, D. Moulin, E. Sellers, A. H. Ngoc, J. Pain Symptom Manage. 2007, 34, 171-182.

A. Cahana, A. Carota, M. L. Montadon, J. M. Annoni, Anesth. Analg. 2004, 98, 1581;

I. W. Tretmont-Lukats, V. Challapalli, E. D. McNicol, J. Lau, D. B. Carr, Anesth. Analg. 2005, 101, 1738.

“https://clinicaltrials.gov/ct2/show/study/NCT01655823?term=TTX&rank=2”, “A Randomized, Double-Blind, Dose-Finding, Placebo Controlled, Phase II, Multicenter Study of Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain” U. S. National Library of Medicine, Results first posted: October 30, 2018; Last accessed: January 25, 2019.

S. Lu, D. Wong, W. Korz, CA 294085, 1973;

H. H. Bushmann, J. M. V. Hernandez, J. M. Baeyens, S. Lu, D. Wong, W. Korz, US 20170000797, 2017;

H. H. Bushmann, J. M. V. Hernandez, J. M. Baeyens, US 9018222, 2015;

H. H. Bushmann, J. M. V. Hernandez, J. M. Baeyens, WO 2007110221, 2007.

S. Chen, L. Ren, Z. Huang, Chin. J. Pharmacol. Toxicol. 2001, 15, 434-440.

J. Shi, T.-T. Liu, X. Wang, D. H. Epstein, L.-Y. Zhao, X.-L. Zhang, L. Lu, Pharmacol. Biochem. Behav. 2009, 92, 603-607.

H. Song, J. Li, C.-L. Lu, L. Kang, L. Xie, Y.-Y. Zhang, X.-B. Zhou, S. Zhong, Clin. Exp. Pharmacol. Physiol. 2011, 38, 510-514.

R. Chau, J. A. Kalaitzis, B. A. Neilan, Aquat. Toxicol. 2011, 104, 61-72.

J. A. Kalaitzis, R. Chau, G. S. Kohli, S. A. Murray, B. A. Neilan, Toxicon 2010, 56, 244-258.

E. M. Lehman, E. D. Brodie, Toxicon 2004, 44, 243-249.

Y. Kotaki, Y. Shimizu, J. Am. Chem. Soc. 1993, 115, 827-830.

M. Yotsu-Yamashita, Y. Abe, Y. Kudo, R. Ritson-Williams, V. J. Paul, K. Konoki, Y. Cho, M. Adachi, T. Imazu, T. Nishikawa, M. Isobe, Mar. Drugs 2013, 11, 2799-2813.

M. Yotsu-Yamashita, Y. Yamagishi, T. Yasumoto, Tetrahedron Lett. 1995, 36, 9329-9332.

M. Yotsu-Yamashita, B. Schimmele, T. Yasumoto, Biosci. Biotechnol. Biochem. 1999, 63, 961-963.

J. H. Jang, M. Yotsu-Yamashita, Toxicon 2007, 50, 947-951.

T. Yasumoto, M. Yotsu, M. Murata, H. Naoki, J. Am. Chem. Soc. 1988, 110, 2344-2345.

S. S. Khora, T. Yasumoto, Tetrahedron Lett. 1989, 30, 4393-4394.

M. Yotsu-Yamashita, Y. Hayashi, S. S. Khora, S. Sato, T. Yasumoto, Biosci. Biotechnol. Biochem. 1992, 56, 370-371.

Y. Kudo, Y. Yamashita, D. Mebs, Y. Cho, K. Konoki, T. Yasumoto, M. Yotsu-Yamashita, Angew. Chem. Int. Ed. 2014, 53, 14546-14549;

Angew. Chem. 2014, 126, 14774-14777.

Y. Kudo, T. Yasumoto, D. Mebs, Y. Cho, K. Konoki, M. Yotsu-Yamashita, Angew. Chem. Int. Ed. 2016, 55, 8728-8731;

Angew. Chem. 2016, 128, 8870-8873.

M. Nakamura, T. Yasumoto, Toxicon 1985, 23, 271-276.

U. Koert, Angew. Chem. Int. Ed. 2004, 43, 5572-5576;

Angew. Chem. 2004, 116, 5690-5694.

J. Chau, M. A. Ciufolini, Mar. Drugs 2011, 9, 2046-2074.

Y. Kishi, F. Nakatsubo, M. Aratani, T. Goto, S. Inoue, H. Kakoi, S. Sugiura, Tetrahedron Lett. 1970, 11, 5127-5128;

Y. Kishi, F. Nakatsubo, M. Aratani, T. Goto, S. Inoue, H. Kakoi, Tetrahedron Lett. 1970, 11, 5129-5132;

Y. Kishi, M. Aratani, T. Fukuyama, F. Nakatsubo, T. Goto, S. Inoue, H. Tanino, S. Sugiura, H. Kakoi, J. Am. Chem. Soc. 1972, 94, 9217-9219;

Y. Kishi, T. Fukuyama, M. Aratani, F. Nakatsubo, T. Goto, S. Inoue, H. Tanino, S. Sugiura, H. Kakoi, J. Am. Chem. Soc. 1972, 94, 9219-9221.

H. Tanino, S. Inoue, Tetrahedron Lett. 1974, 15, 335-338.

J. F. W. Keana, F. P. Mason, J. S. Bland, J. Org. Chem. 1969, 34, 3705-3707;

J. F. W. Keana, P. J. Boyle, M. Erion, R. Hartling, J. R. Husman, J. E. Richman, R. B. Roman, R. M. Wah, J. Org. Chem. 1983, 48, 3621-3626;

J. F. W. Keana, J. S. Bland, P. J. Boyle, M. Erion, R. Hartling, J. R. Husman, R. B. Roman, G. Ferguson, M. Parvez, J. Org. Chem. 1983, 48, 3627-3631.

J. F. W. Keana, C. U. Kim, J. Org. Chem. 1970, 35, 1093-1096;

J. F. W. Keana, C. U. Kim, J. Org. Chem. 1971, 36, 118-127.

R. A. Alonso, C. S. Burgey, B. V. Rao, G. D. Vite, R. Vollerthun, M. A. Zottola, B. Fraser-Reid, J. Am. Chem. Soc. 1993, 115, 6666-6672.

Y. Kishi, M. Aratani, T. Fukuyama, F. Nakatsubo, T. Goto, S. Inoue, H. Tanino, S. Sugiura, H. Kakoi, J. Am. Chem. Soc. 1972, 94, 9217-9219.

B. Fraser-Reid, R. C. Anderson, Prog. Chem. Org. Nat. Prod. 1980, 39, 1-61.

D. R. Mootoo, P. Konradsson, U. Udodong, B. Fraser-Reid, J. Am. Chem. Soc. 1988, 110, 5583-5584.

C. S. Burgey, R. Vollerthun, B. Fraser-Reid, J. Org. Chem. 1996, 61, 1609-1618;

B. Fraser-Reid, C. S. Burgey, R. Vollerthun, Pure Appl. Chem. 1998, 70, 285-288.

D. F. Taber, P. H. Storck, J. Org. Chem. 2003, 68, 7768-7771.

M. A. Tius, A. H. Fauq, J. Org. Chem. 1983, 48, 4131-4132.

Y. Ohtani, T. Shinada, Y. Ohfune, Synlett 2003, 619-622.

M. Isobe, T. Nishikawa, N. Fukami, T. Goto, Pure Appl. Chem. 1987, 59, 399-406;

M. Isobe, T. Nishikawa, S. Pikul, T. Goto, Tetrahedron Lett. 1987, 28, 6485-6488;

M. Isobe, Y. Fukuda, T. Nishikawa, P. Chabert, T. Kawai, T. Goto, Tetrahedron Lett. 1990, 31, 3327-3330;

N. Yamamoto, M. Isobe, Tetrahedron 1993, 49, 6581-6590;

N. Yamamoto, M. Isobe, Chem. Lett. 1994, 23, 2299-2302;

N. Yamamoto, T. Nishikawa, M. Isobe, Synlett 1995, 505-506;

M. Bamba, T. Nishikawa, M. Isobe, Tetrahedron Lett. 1996, 37, 8199-8202;

M. Bamba, T. Nishikawa, M. Isobe, Tetrahedron 1998, 54, 6639-6650;

M. Bamba, T. Nishikawa, M. Isobe, Synlett 1998, 371-372;

T. Nishikawa, N. Ohyabu, N. Yamamoto, M. Isobe, Tetrahedron 1999, 55, 4325-4340;

T. Nishikawa, M. Asai, N. Ohyabu, N. Yamamoto, Y. Fukuda, M. Isobe, Tetrahedron 2001, 57, 3875-3883;

T. Nishikawa, Y. Koide, M. Adachi, M. Isobe, Bull. Chem. Soc. Jpn. 2010, 83, 66-68;

Y. Satake, T. Nishikawa, T. Hiramamtsu, H. Araki, M. Isobe, Synthesis 2010, 1992-1998.

M. Asai, T. Nishikawa, N. Ohyabu, N. Yamamoto, M. Isobe, Tetrahedron 2001, 57, 4543-4558;

M. Adachi, T. Imazu, M. Isobe, T. Nishikawa, J. Org. Chem. 2013, 78, 1699-1705.

T. Nishikawa, M. Asai, M. Isobe, J. Am. Chem. Soc. 2002, 124, 7847-7852.

T. Nishikawa, D. Urabe, K. Yoshida, T. Iwabuchi, M. Asai, M. Isobe, Org. Lett. 2002, 4, 2679-2682;

T. Nishikawa, D. Urabe, K. Yoshida, T. Iwabuchi, M. Asai, M. Isobe, Chem. Eur. J. 2004, 10, 452-462;

T. Nishikawa, D. Urabe, K. Yoshida, T. Iwabuchi, M. Asai, M. Isobe, Pure Appl. Chem. 2003, 75, 251-257.

M. Adachi, R. Sakakibara, Y. Satake, M. Isobe, T. Nishikawa, Chem. Lett. 2014, 43, 1719-1721.

Y. Satake, M. Adachi, S. Tokoro, M. Yotsu-Yamashita, M. Isobe, T. Nishikawa, Chem. Asian J. 2014, 9, 1922-1932.

T. Umezawa, T. Hayashi, H. Sakai, H. Teramoto, T. Yoshikawa, M. Izumida, Y. Tamatani, T. Hirose, Y. Ohfune, T. Shinada, Org. Lett. 2006, 8, 4971-4974.

N. Ohyabu, T. Nishikawa, M. Isobe, J. Am. Chem. Soc. 2003, 125, 8798-8805.

T. Nishikawa, D. Urabe, M. Isobe, Angew. Chem. Int. Ed. 2004, 43, 4782-4785;

Angew. Chem. 2004, 116, 4886-4889.

D. Urabe, T. Nishikawa, M. Isobe, Chem. Asian J. 2006, 1, 125-135.

T. Nishikawa, D. Urabe, M. Adachi, M. Isobe, Synlett 2015, 26, 1930-1939.

T. Nishikawa, M. Asai, N. Ohyabu, N. Yamamoto, M. Isobe, Angew. Chem. Int. Ed. 1999, 38, 3081-3084;

Angew. Chem. 1999, 111, 3268-3271.

T. Nishikawa, M. Isobe, Chem. Rec. 2013, 13, 286-302.

A. Hinman, J. Du Bois, J. Am. Chem. Soc. 2003, 125, 11510-11511.

E. M. Carreira, J. Du Bois, J. Am. Chem. Soc. 1995, 117, 8106-8125.

K. Sato, S. Akai, N. Sugita, T. Ohsawa, T. Kogure, H. Shoji, J. Yoshimura, J. Org. Chem. 2005, 70, 7496-7504.

K. Sato, Y. Kajihara, Y. Nakamura, J. Yoshimura, Chem. Lett. 1991, 20, 1559-1562.

K. Sato, S. Akai, H. Shoji, N. Sugita, S. Yoshida, Y. Nagai, K. Suzuki, Y. Nakamura, Y. Kajihara, M. Funabashi, J. Yoshimura, J. Org. Chem. 2008, 73, 1234-1242.

S. Akai, H. Seki, N. Sugita, T. Kogure, N. Nishizawa, K. Suzuki, Y. Nakamura, Y. Kajihara, J. Yoshimura, K. Sato, Bull. Chem. Soc. Jpn. 2010, 83, 279-287.

J. K. Fairweather, M. J. McDonough, R. V. Stick, D. M. G. Tilbrook, Aust. J. Chem. 2004, 57, 197-205.

K. Sato, S. Akai, J. Yoshimura, Nat. Prod. Commun. 2015, 10, 691-702.

A. Manabe, Y. Ohfune, T. Shinada, Tetrahedron Lett. 2014, 55, 6077-6080.

K. Dota, T. Shimizu, S. Hasegawa, M. Miyashita, K. Tanio, Tetrahedron Lett. 2011, 52, 910-912.

B. A. Mendelsohn, M. A. Ciufolini, Org. Lett. 2009, 11, 4736-4739.

H. Andersen, N. B. Das, R. D. Joergensen, G. Kjeldsen, J. S. Knudsen, S. C. Sharma, K. B. G. Torsell, Acta. Chem. Scand. B 1982, 36, 1-14.

J. Chau, S. Xu, M. A. Ciufolini, J. Org. Chem. 2013, 78, 11901-11910.

L. Cecchi, F. De Sarlo, F. Machetti, Chem. Eur. J. 2008, 14, 7903-7912;

E. Trogu, F. De Sarlo, F. Machetti, Chem. Eur. J. 2009, 15, 7940-7948.

J. Chau, MSc thesis, University of British Columbia (Canada), 2012.

S. Xu, M. A. Ciufolini, Org. Lett. 2015, 17, 2424-2427.

S. Torrente, B. Noya, M. D. Paredes, R. Alonso, J. Org. Chem. 1997, 62, 6710-6711;

S. Torrente, B. Noya, V. Branchadell, R. Alonso, J. Org. Chem. 2003, 68, 4772-4783.

B. Noya, R. Alonso, Tetrahedron Lett. 1997, 38, 2745-2748;

B. Noya, M. D. Paredes, L. Ozores, R. Alonso, J. Org. Chem. 2000, 65, 5960-5968.

L. Ozores, F. Cagide, R. Alonso, Synlett 2004, 2746-2750;

M. Fernández-González, R. Alonso, J. Org. Chem. 2006, 71, 6767-6775.

J. C. Ortiz, L. Ozores, F. Cagide-Fagín, R. Alonso, Chem. Commun. 2006, 4239-4241.

P. Martínez-Bescos, F. Cagide-Fagín, L. F. Roa, J. C. Ortiz-Lara, K. Kierus, L. Ozores-Viturro, M. Fernández-González, R. Alonso, J. Org. Chem. 2008, 73, 3745-3753.

F. Cagide-Fagín, R. Alonso, Eur. J. Org. Chem. 2010, 6741-6747;

K. Sato, S. Akai, H. Shoji, N. Sugita, S. Yoshida, Y. Nagai, K. Suzuki, Y. Nakamura, Y. Kajihara, M. Funabashi, J. Yoshimura, J. Org. Chem. 2008, 73, 1234-1242.

F. Cagide-Fagín, O. Nieto-García, H. Lago-Santomé, R. Alonso, J. Org. Chem. 2012, 77, 11377-11382.

For a recent review of synthesis of Amaryllidaceae alkloids see: M. Ghavre, J. Froese, M. Pour, T. Hudlicky, Angew. Chem. Int. Ed. 2016, 55, 5642-5691;

Angew. Chem. 2016, 128, 5732-5784.

H. Lago-Santomé, R. Meana-Pañeda, R. Alonso, J. Org. Chem. 2014, 79, 4300-4305.

H. Guenther, G. Jikeli, Chem. Rev. 1977, 77, 599-637.

T. Itoh, M. Watanabe, T. Fukuyama, Synlett 2002, 1323-1325.

T. Maehara, K. Motoyama, T. Toma, S. Yokoshima, T. Fukuyama, Angew. Chem. Int. Ed. 2017, 56, 1549-1552;

Angew. Chem. 2017, 129, 1571-1574.

For the discovery of chemoenzymatic dihydroxylation see:

D. T. Gibson, J. R. Koch, R. E. Kallio, Biochemistry 1968, 7, 2653-2662;

D. T. Gibson, J. R. Koch, C. L. Schuld, R. E. Kallio, Biochemistry 1968, 7, 3795-3802; for the report on recombinant strain see:

G. J. Zylstra, D. T. Gibson, J. Biol. Chem. 1989, 264, 14940-14946; for the medium-scale fermentation protocol see:

M. A. Endoma, V. P. Bui, J. Hansen, T. Hudlicky, Org. Process Res. Dev. 2002, 6, 525-532.

For reviews on the use of metabolites such as diene diols 313 and 318 in synthesis see:

E. S. Taher, M. G. Banwell, J. N. Buckler, Q. Yan, P. Lan, Chem. Rec. 2018, 18, 239-264;

M. G. Banwell, B. Bolte, J. N. Buckler, E. L. Chang, P. Lan, E. S. Taher, L. V. White, A. C. Willis, J. Proc. Royal Soc. New South Wales, 2016, parts 1 & 2, pp. 34-50;

S. E. Lewis, Chem. Commun. 2014, 50, 2821-2830;

U. Rinner in Comprehensive Chirality, Vol. 2 (Eds.: E. M. Carreira, H. Yamamoto), Elsevier, Amsterdam, 2012, p. 240;

D. J.-Y. D. Bon, B. Lee, M. G. Banwell, I. A. Cade, Chim. Oggi 2012, 30, 22-27;

T. Hudlicky, J. W. Reed, Synlett 2009, 685-703;

T. Hudlicky, J. W. Reed, Chem. Soc. Rev. 2009, 38, 3117-3132;

D. R. Boyd, T. D. H. Bugg, Org. Biomol. Chem. 2006, 4, 181-192;

R. A. Johnson, in Org. React., Vol. 63 (Ed.: L. E. Overman), Wiley, New York, 2004, pp. 117-264;

M. G. Banwell, A. J. Edwards, K. A. Harfoot, K. A. Jolliffe, M. D. McLeod, K. J. McRae, S. G. Stewart, M. Vogtle, Pure Appl. Chem. 2003, 75, 223-230;

D. R. Boyd, N. D. Sharma, J. Mol. Catal. B 2002, 19-20, 31-42;

D. R. Boyd, N. D. Sharma, C. C. R. Allen, D. R. Boyd, N. D. Sharma, C. C. R. Allen, Curr. Opin. Biotechnol. 2001, 12, 564-573;

T. Hudlicky, D. Gonzalez, D. T. Gibson, Aldrichimica Acta 1999, 32, 35-62;

D. R. Boyd, G. N. Sheldrake, Nat. Prod. Rep. 1998, 15, 309-324;

J. W. Reed, T. Hudlicky, In Advances in Asymmetric Synthesis, Vol. 1 (Ed.: A.Hassner), JAI Press, Greenwich, 1995, pp. 271-312;

S. M. Brow, T. Hudlicky, In Organic Synthesis: Theory and Applications, Vol. 2 (Ed.: T. Hudlicky), JAI Press, Greenwich, 1993, pp. 113-176;

H. A. J. Carless, Tetrahedron: Asymmetry 1992, 3, 795-826;

D. A. Widdowson, D. W. Ribbons, D. D. Thomas, Janssen Chim. Acta 1990, 8, 3-9.

D. Baidilov, M. Makarova, L. Rycek, T. Hudlicky, Synthesis 2018, 50, 4606-4610.

D. Baidilov, L. Rycek, J. F. Trant, J. Froese, B. Murphy, T. Hudlicky, Angew. Chem. Int. Ed. 2018, 57, 10994-10998;

Angew. Chem. 2018, 130, 11160-11164.

D. F. Hwang, O. Arakawa, T. Saito, T. Noguchi, U. Shimidu, K. Tsukamoto, Y. Shida, K. Hashimoto, Mar. Biol. 1989, 100, 327-332.

T. Noguchi, J. K. Jeon, O. Arakawa, H. Sugita, Y. Deguchi, Y. Shida, K. Hashimoto, J. Biochem. 1986, 99, 311-314.

M. Adachi, T. Imazu, R. Sakakibara, Y. Satake, M. Isobe, T. Nishikawa, Chem. Eur. J. 2014, 20, 1247-1251.

K. Tsuda, S. Ikuma, M. Kawamura, R. Tachikawa, K. Sakai, C. Tamura, O. Amakasu, Chem. Pharm. Bull. 1964, 12, 1357-1374.

J. Jang, M. Yotsu-Yamashita, Toxicon 2006, 48, 980-987.

The paper on isolation did not provide the data on optical rotation. Although it may be likely that most isolated TTX analogues belong to the same enantiomeric series, one should be careful to assign their absolute configuration on the basis of an enantioselective total synthesis only, without direct comparison of signs of rotation with the material isolated from the natural source.

X.-J. Wang, R.-C. Yu, X. Luo, M.-J. Zhou, X.-T. Liu, Toxicon 2008, 52, 55-61.

P. Rodriguez, A. Alfonso, C. Vale, C. Alfonso, P. Vale, A. Tellez, L. M. Botana, Anal. Chem. 2008, 80, 5622-5629.

M. D. Toscano, M. Frederickson, D. P. Evans, J. R. Coggins, C. Abell, C. Gonzales-Bello, Org. Biomol. Chem. 2003, 1, 2075-2083.

T. Umezawa, T. Shinada, Y. Ohfune, Chem. Lett. 2010, 39, 1281-1282.

Y. Kudo, T. Yasumoto, K. Konoki, Y. Cho, M. Yotsu-Yamashita, Mar. Drugs 2012, 10, 655-667.

Anhydro-5,6,11-trideoxyTTX listed in ref. [140] is likely the alkaloid 23 (or its mixture with 4,4a-anhydro-5,6,11-trideoxyTTX) on the basis of email correspondence with Professor Yotsu-Yamashita, which is gratefully acknowledged.

A. Endoa, S. S. Khora, M. Murata, H. Naoki, T. Yasumoto, Tetrahedron Lett. 1988, 29, 4127-4128.

L. A. Pavelka, F. A. Fuhrman, H. S. Mosher, Heterocycles 1982, 17, 225-230.

Y. H. Kim, G. B. Brown, H. S. Mosher, F. A. Fuhrman, Science 1975, 189, 151-152.

M. Yotsu, T. Yasumoto, Y. H. Kim, H. Naoki, C. Y. Kao, Tetrahedron Lett. 1990, 31, 3187-3190.

M. Yotsu-Yamashita, E. Tateki, Toxicon 2010, 55, 153-156.

Immunosensors for Assay of Toxic Biological Warfare Agents